endometriosis.org ltd
endometriosis.org ltd Company Information
Company Number
05331208
Next Accounts
Oct 2025
Industry
Other publishing activities
Directors
Shareholders
lone hummelshoj
Group Structure
View All
Contact
Registered Address
89 southgate road, london, N1 3JS
Website
endometriosis.orgendometriosis.org ltd Estimated Valuation
Pomanda estimates the enterprise value of ENDOMETRIOSIS.ORG LTD at £1.1k based on a Turnover of £1.7k and 0.6x industry multiple (adjusted for size and gross margin).
endometriosis.org ltd Estimated Valuation
Pomanda estimates the enterprise value of ENDOMETRIOSIS.ORG LTD at £1.4k based on an EBITDA of £405 and a 3.4x industry multiple (adjusted for size and gross margin).
endometriosis.org ltd Estimated Valuation
Pomanda estimates the enterprise value of ENDOMETRIOSIS.ORG LTD at £0 based on Net Assets of £-17k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Endometriosis.org Ltd Overview
Endometriosis.org Ltd is a live company located in london, N1 3JS with a Companies House number of 05331208. It operates in the other publishing activities sector, SIC Code 58190. Founded in January 2005, it's largest shareholder is lone hummelshoj with a 100% stake. Endometriosis.org Ltd is a established, micro sized company, Pomanda has estimated its turnover at £1.7k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Endometriosis.org Ltd Health Check
Pomanda's financial health check has awarded Endometriosis.Org Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £1.7k, make it smaller than the average company (£986.2k)
- Endometriosis.org Ltd
£986.2k - Industry AVG
Growth
3 year (CAGR) sales growth of -3%, show it is growing at a slower rate (7%)
- Endometriosis.org Ltd
7% - Industry AVG
Production
with a gross margin of 57.9%, this company has a comparable cost of product (57.9%)
- Endometriosis.org Ltd
57.9% - Industry AVG
Profitability
an operating margin of 23.3% make it more profitable than the average company (6.1%)
- Endometriosis.org Ltd
6.1% - Industry AVG
Employees
with 1 employees, this is below the industry average (22)
- Endometriosis.org Ltd
22 - Industry AVG
Pay Structure
on an average salary of £53.8k, the company has an equivalent pay structure (£53.8k)
- Endometriosis.org Ltd
£53.8k - Industry AVG
Efficiency
resulting in sales per employee of £1.7k, this is less efficient (£116.3k)
- Endometriosis.org Ltd
£116.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Endometriosis.org Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 231 days, this is slower than average (41 days)
- Endometriosis.org Ltd
41 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Endometriosis.org Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (32 weeks)
0 weeks - Endometriosis.org Ltd
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 8982.2%, this is a higher level of debt than the average (53%)
8982.2% - Endometriosis.org Ltd
53% - Industry AVG
ENDOMETRIOSIS.ORG LTD financials
Endometriosis.Org Ltd's latest turnover from January 2024 is estimated at £1.7 thousand and the company has net assets of -£17 thousand. According to their latest financial statements, we estimate that Endometriosis.Org Ltd has 1 employee and maintains cash reserves of £191 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10,081 | 8,326 | |||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 0 | 0 | |||||||||||||
| Interest Receivable | 0 | 0 | |||||||||||||
| Pre-Tax Profit | 726 | -1,286 | |||||||||||||
| Tax | 0 | 0 | |||||||||||||
| Profit After Tax | 726 | -1,286 | |||||||||||||
| Dividends Paid | 0 | 0 | |||||||||||||
| Retained Profit | 726 | -1,286 | |||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 191 | 2,388 | 3,119 | 7,725 | 2,153 | 5,015 | 88 | 1,333 | 538 | 81 | 1,620 | 209 | 520 | 1,118 | 2,925 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 191 | 2,388 | 3,119 | 7,725 | 2,153 | 5,015 | 88 | 1,333 | 538 | 81 | 1,620 | 209 | 520 | 1,118 | 2,925 |
| total assets | 191 | 2,388 | 3,119 | 7,725 | 2,153 | 5,015 | 88 | 1,333 | 538 | 81 | 1,620 | 209 | 520 | 1,118 | 2,925 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 465 | 450 | 450 | 425 | 425 | 425 | 425 | 400 | 400 | 6,083 | 6,954 | 6,175 | 7,254 | 0 | 0 |
| Group/Directors Accounts | 5,514 | 4,636 | 8,099 | 9,017 | 6,736 | 7,001 | 5,464 | 5,106 | 4,874 | 0 | 0 | 0 | 0 | 3,502 | 4,631 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 11,177 | 14,622 | 9,372 | 10,029 | 7,736 | 7,736 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 350 | 1,754 |
| total current liabilities | 17,156 | 19,708 | 17,921 | 19,471 | 14,897 | 15,162 | 5,889 | 5,506 | 5,274 | 6,083 | 6,954 | 6,175 | 7,254 | 3,852 | 6,385 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 17,156 | 19,708 | 17,921 | 19,471 | 14,897 | 15,162 | 5,889 | 5,506 | 5,274 | 6,083 | 6,954 | 6,175 | 7,254 | 3,852 | 6,385 |
| net assets | -16,965 | -17,320 | -14,802 | -11,746 | -12,744 | -10,147 | -5,801 | -4,173 | -4,736 | -6,002 | -5,334 | -5,966 | -6,734 | -2,734 | -3,460 |
| total shareholders funds | -16,965 | -17,320 | -14,802 | -11,746 | -12,744 | -10,147 | -5,801 | -4,173 | -4,736 | -6,002 | -5,334 | -5,966 | -6,734 | -2,734 | -3,460 |
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 15 | 0 | 25 | 0 | 0 | 0 | 25 | 0 | -5,683 | -871 | 779 | -1,079 | 7,254 | 0 | 0 |
| Accruals and Deferred Income | -3,445 | 5,250 | -657 | 2,293 | 0 | 7,736 | 0 | 0 | 0 | 0 | 0 | 0 | -350 | -1,404 | 1,754 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 878 | -3,463 | -918 | 2,281 | -265 | 1,537 | 358 | 232 | 4,874 | 0 | 0 | 0 | -3,502 | -1,129 | 4,631 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | |||||||||||||
| cash flow from financing | -1,129 | 2,457 | |||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -2,197 | -731 | -4,606 | 5,572 | -2,862 | 4,927 | -1,245 | 795 | 457 | -1,539 | 1,411 | -311 | -598 | -1,807 | 2,925 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -2,197 | -731 | -4,606 | 5,572 | -2,862 | 4,927 | -1,245 | 795 | 457 | -1,539 | 1,411 | -311 | -598 | -1,807 | 2,925 |
endometriosis.org ltd Credit Report and Business Information
Endometriosis.org Ltd Competitor Analysis
Perform a competitor analysis for endometriosis.org ltd by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other micro companies, companies in N 1 area or any other competitors across 12 key performance metrics.
endometriosis.org ltd Ownership
ENDOMETRIOSIS.ORG LTD group structure
Endometriosis.Org Ltd has no subsidiary companies.
Ultimate parent company
ENDOMETRIOSIS.ORG LTD
05331208
endometriosis.org ltd directors
Endometriosis.Org Ltd currently has 1 director, Ms Lone Hummelshoj serving since Jan 2005.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Lone Hummelshoj | 60 years | Jan 2005 | - | Director |
P&L
January 2024turnover
1.7k
-10%
operating profit
405.6
0%
gross margin
57.9%
+0.53%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
-17k
-0.02%
total assets
191
-0.92%
cash
191
-0.92%
net assets
Total assets minus all liabilities
endometriosis.org ltd company details
company number
05331208
Type
Private limited with Share Capital
industry
58190 - Other publishing activities
incorporation date
January 2005
age
19
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
January 2024
previous names
N/A
accountant
CONFIDENTIAL ACCOUNTING MANAGEMENT LIMITED
auditor
-
address
89 southgate road, london, N1 3JS
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
endometriosis.org ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to endometriosis.org ltd.
endometriosis.org ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ENDOMETRIOSIS.ORG LTD. This can take several minutes, an email will notify you when this has completed.
endometriosis.org ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
